Topics

Ziextenzo™ biosimilar has received approval from the FDA

09:35 EST 8 Nov 2019 | European Pharmaceutical Review

The FDA has approved Sandoz's biosimilar Ziextenzo and the company now intends to launch it in the US as soon as possible this year.

The post Ziextenzo™ biosimilar has received approval from the FDA appeared first on European Pharmaceutical Review.

Original Article: Ziextenzo™ biosimilar has received approval from the FDA

NEXT ARTICLE

More From BioPortfolio on "Ziextenzo™ biosimilar has received approval from the FDA"

Quick Search

Relevant Topic

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...